Tandem Diabetes Care Inc (NAS:TNDM)
$ 33.81 1.71 (5.33%) Market Cap: 2.11 Bil Enterprise Value: 1.98 Bil PE Ratio: 0 PB Ratio: 8.85 GF Score: 82/100

Tandem Diabetes Care Inc at Berenberg US Conference (Virtual) Transcript

May 18, 2021 / 07:00PM GMT
Release Date Price: $81.63 (+3.95%)
Ravi Misra
Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst

Hi. Good afternoon. Welcome to the Berenberg Capital Markets Conference USA. We're absolutely thrilled to have the management of Tandem Diabetes here, CFO, Leigh Vosseller; and CAO, Susan Morrison. Thank you for the next kind of 45 minutes of your time. (Operator Instructions)

Questions & Answers

Ravi Misra
Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst

So I just want to maybe start off setting the picture. You're 1 of 3 insulin pump delivery systems from a noninjection perspective in the United States and worldwide, pretty much one of a handful. Can you maybe talk about the market opportunity as you see it between the type 1 patient and the type 2 patients. Sorry, we have a very excited Tandem investor in the background.

So if we can think about sort of this goal that you've discussed in the past of around 0.5 million patients by 20 (inaudible), how do we think about it from a kind of type 1 versus type 2 perspective? Where do you see the mix

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot